Takeda Escapes COVID Impact With 2% Underlying Growth

R&D Spend To Rise 15%

 
• By Ian Haydock
  
Takeda Tokyo HQ entrance
Takeda spends to progress Wave 1 pipeline • Source: Takeda
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip